Bioequivalence Study of Ferric Carboxymaltose Injection in Healthy Chinese Participants

NCT06895993 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

84

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Adult

Interventions

DRUG: Ferric Carboxymaltose Injection
DRUG: Ferric Carboxymaltose Injection [Injectafer®]

Sponsor

Sichuan Huiyu Pharmaceutical Co., Ltd

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]